Bausch + Lomb, a global eye health business of Bausch Health Companies Inc (NYSE/TSX: BHC), announced on Tuesday the US launch of Alaway(R) Preservative Free (ketotifen fumarate ophthalmic solution 0.035%) antihistamine eye drops.
The company stated that the product is the first and only over-the-counter (OTC) preservative-free antihistamine eye itch relief drop approved by the US Food and Drug Administration (FDA).
'As we head into Spring, millions of Americans with allergies will experience itchy eyes, one of the eye symptoms that affects approximately 80% of people with allergies,' said Joe Gordon, US president, Bausch + Lomb. 'With the availability of Alaway(R) Preservative Free antihistamine eye drops, consumers now have a new over-the-counter option that provides fast, lasting eye itch relief without the use of preservatives.'
Alaway Preservative-Free will be available for purchase at most US national retailers, including Walgreens, CVS, Walmart and Amazon. A 10-day supply (20 single-dose vials) will have a manufacturer's suggested retail price of USD14.99.
CSL's ANDEMBRY receives European approval to prevent attacks of hereditary angioedema
NICE recommends ALK's ACARIZAX for house dust mite allergic rhinitis treatment in UK's NHS
European Commission approves Palforzia for toddlers with peanut allergy
Eli Lilly and Co receives approval from FDA for Zepbound
CSL gains EMA backing for Garadacimab as HAE prophylactic treatment
Merck initiates Phase 3 trial for LAGEVRIO (molnupiravir)
Allergy Therapeutics reports positive data from VLP Peanut PROTECT trial
CBC Group acquires UCB's mature neurology and allergy business in China
Allergy Therapeutics begins Phase III trial for grass allergy treatment in children